{"id":39077,"date":"2023-03-03T12:41:40","date_gmt":"2023-03-03T07:11:40","guid":{"rendered":"http:\/\/finservwealth.com\/alembic-pharma-falls-5-after-board-nod-to-rs-1150-cr-impairment-charges\/"},"modified":"2023-03-03T12:41:40","modified_gmt":"2023-03-03T07:11:40","slug":"alembic-pharma-falls-5-after-board-nod-to-rs-1150-cr-impairment-charges","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/alembic-pharma-falls-5-after-board-nod-to-rs-1150-cr-impairment-charges\/","title":{"rendered":"Alembic Pharma falls 5% after board nod to Rs 1,150-cr impairment charges"},"content":{"rendered":"<p> Shares of Alembic Pharma hit a fresh 52-week low after the company\u00e2\u20ac\u2122s board approved Rs 1,150 crore impairment charges for three manufacturing facilities in Gujarat.<\/p><div id=\"finse-2779385018\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/buzzing-stocks\/alembic-pharma-falls-5-after-board-nod-to-rs-1150-cr-impairment-charges_16916551.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0Shares of Alembic Pharma hit a fresh 52-week low after the company\u00e2\u20ac\u2122s board approved Rs 1,150 crore impairment charges for three manufacturing facilities in Gujarat. Shares of Alembic Pharma hit a fresh 52-week low after the company\u00e2\u20ac\u2122s board approved Rs 1,150 crore impairment charges for three manufacturing facilities in Gujarat.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/buzzing-stocks\/alembic-pharma-falls-5-after-board-nod-to-rs-1150-cr-impairment-charges_16916551.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> Shares of Alembic Pharma hit a fresh 52-week low after the company\u00e2\u20ac\u2122s board approved Rs 1,150 crore impairment charges for three manufacturing facilities in Gujarat.<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/buzzing-stocks\/alembic-pharma-falls-5-after-board-nod-to-rs-1150-cr-impairment-charges_16916551.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0Shares of Alembic Pharma hit a fresh 52-week low after the company\u00e2\u20ac\u2122s board approved Rs 1,150 crore impairment charges for three manufacturing facilities in Gujarat. Shares of Alembic Pharma hit a fresh 52-week low after the company\u00e2\u20ac\u2122s board approved Rs 1,150 crore impairment charges for three manufacturing facilities in Gujarat.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/buzzing-stocks\/alembic-pharma-falls-5-after-board-nod-to-rs-1150-cr-impairment-charges_16916551.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> Shares of Alembic Pharma hit a fresh 52-week low after the company\u00e2\u20ac\u2122s board approved Rs 1,150 crore impairment charges for three manufacturing facilities in Gujarat.<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-39077","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2020\/200x200\/A\/ALEMBIC-PHARMA_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/39077","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=39077"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/39077\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=39077"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=39077"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=39077"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}